Fig. 5.
a) Hydrolysis-resistant D-peptide antagonist to target the PD-1/PD-L1 b) Macrocyclic peptidic inhibitor c) Peptide antagonist of PD-L1 (10) along with its sequence similarities to PD-1
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.